Literature DB >> 6508075

Trimethoprim resistance plasmids.

S G Amyes, I M Gould.   

Abstract

Of 320 patients surveyed in a general hospital's medical wards during a 6-month period in 1981, 18 (5.6%) harboured enterobacteria which contained resistance plasmids conferring resistance to trimethoprim (Tp). At the beginning of the study period, Tp-containing therapy was not the first choice for treatment of infections caused by these bacteria and the incidence of plasmid-determined resistance was 10%. When Tp alone was used as the first choice of treatment of urinary tract infections and the use of this antimicrobial was correspondingly increased, the proportion of strains that contained Tp resistance plasmids (R-plasmids) decreased to 4%. Relatively more patients with Tp-resistant strains in the bowel had significant bacteriuria compared with those without Tp-resistant organisms. The continuing occurrence of Tp-R-plasmid containing strains in the gut was associated with continuing antimicrobial therapy; the strains generally disappeared after antimicrobial therapy was stopped.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6508075

Source DB:  PubMed          Journal:  Ann Microbiol (Paris)        ISSN: 0300-5410


  11 in total

1.  New gene cassettes for trimethoprim resistance, dfr13, and Streptomycin-spectinomycin resistance, aadA4, inserted on a class 1 integron.

Authors:  P V Adrian; C J Thomson; K P Klugman; S G Amyes
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  New trimethoprim-resistant dihydrofolate reductase cassette, dfrXV, inserted in a class 1 integron.

Authors:  P V Adrian; M DU Plessis; K P Klugman; S G Amyes
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

3.  Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype.

Authors:  James R Johnson; Brian Johnston; Michael A Kuskowski; Raul Colodner; Raul Raz
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

4.  Beta-lactam resistance in normal faecal flora from South Africa.

Authors:  P M Shanahan; C J Thomson; S G Amyes
Journal:  Epidemiol Infect       Date:  1995-10       Impact factor: 2.451

5.  The prevalence of antimicrobial resistance in human faecal flora in South Africa.

Authors:  P M Shanahan; B A Wylie; P V Adrian; H J Koornhof; C J Thomson; S G Amyes
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

6.  Molecular analysis of and identification of antibiotic resistance genes in clinical isolates of Salmonella typhi from India.

Authors:  P M Shanahan; M V Jesudason; C J Thomson; S G Amyes
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

7.  High-level trimethoprim resistance in urinary bacteria.

Authors:  S G Amyes; C J Doherty; H K Young
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

8.  Trimethoprim resistance in commensal bacteria isolated from farm animals.

Authors:  S G Amyes
Journal:  Epidemiol Infect       Date:  1987-02       Impact factor: 2.451

9.  Trimethoprim resistant dihydrofolate reductases in normal faecal flora isolated in India.

Authors:  S Tait; S G Amyes
Journal:  Epidemiol Infect       Date:  1994-10       Impact factor: 2.451

10.  Plasmid penicillin resistance in Vibrio cholerae: identification of new beta-lactamase SAR-1.

Authors:  A J Reid; S G Amyes
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.